SIGNIFY HEALTH INC -CLASS A (SGFY) Stock Fundamental Analysis
NYSE:SGFY - New York Stock Exchange, Inc. - US82671G1004 - Common Stock - Currency: USD
Overall SGFY gets a fundamental rating of 4 out of 10. We evaluated SGFY against 102 industry peers in the Health Care Providers & Services industry. SGFY scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. SGFY is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
SGFY had negative earnings in the past year.
In the past year SGFY had a positive cash flow from operations.
In the past 5 years SGFY reported 4 times negative net income.
Each year in the past 5 years SGFY had a positive operating cash flow.
1.2 Ratios
SGFY has negative profitability rations, so we won't be analyzing them here.
The Return On Invested Capital of SGFY (6.14%) is better than 67.26% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | N/A | ||
| ROE | N/A | ||
| ROIC | 6.14% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With an excellent Operating Margin value of 13.53%, SGFY belongs to the best of the industry, outperforming 89.38% of the companies in the same industry.
In the last couple of years the Operating Margin of SGFY has grown nicely.
Looking at the Gross Margin, with a value of 45.33%, SGFY is in the better half of the industry, outperforming 72.57% of the companies in the same industry.
SGFY's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 13.53% | ||
| PM (TTM) | N/A | ||
| GM | 45.33% |
OM growth 3Y50.3%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.69%
GM growth 5YN/A
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so SGFY is destroying value.
Compared to 1 year ago, SGFY has more shares outstanding
Compared to 1 year ago, SGFY has a worse debt to assets ratio.
2.2 Solvency
SGFY has an Altman-Z score of 3.36. This indicates that SGFY is financially healthy and has little risk of bankruptcy at the moment.
SGFY has a better Altman-Z score (3.36) than 76.99% of its industry peers.
The Debt to FCF ratio of SGFY is 93.50, which is on the high side as it means it would take SGFY, 93.50 years of fcf income to pay off all of its debts.
SGFY has a Debt to FCF ratio (93.50) which is comparable to the rest of the industry.
SGFY has a Debt/Equity ratio of 0.53. This is a neutral value indicating SGFY is somewhat dependend on debt financing.
SGFY's Debt to Equity ratio of 0.53 is fine compared to the rest of the industry. SGFY outperforms 60.18% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.53 | ||
| Debt/FCF | 93.5 | ||
| Altman-Z | 3.36 |
ROIC/WACC0.66
WACC9.37%
2.3 Liquidity
A Current Ratio of 1.62 indicates that SGFY should not have too much problems paying its short term obligations.
SGFY's Current ratio of 1.62 is fine compared to the rest of the industry. SGFY outperforms 67.26% of its industry peers.
A Quick Ratio of 1.62 indicates that SGFY should not have too much problems paying its short term obligations.
SGFY's Quick ratio of 1.62 is fine compared to the rest of the industry. SGFY outperforms 72.57% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.62 | ||
| Quick Ratio | 1.62 |
3. Growth
3.1 Past
SGFY shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -390.91%.
Looking at the last year, SGFY shows a very strong growth in Revenue. The Revenue has grown by 23.33%.
SGFY shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 17.09% yearly.
EPS 1Y (TTM)-390.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-253.85%
Revenue 1Y (TTM)23.33%
Revenue growth 3Y17.09%
Revenue growth 5YN/A
Sales Q2Q%232.24%
3.2 Future
SGFY is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 93.52% yearly.
Based on estimates for the next years, SGFY will show a quite strong growth in Revenue. The Revenue will grow by 18.33% on average per year.
EPS Next Y200.72%
EPS Next 2Y93.52%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year13.26%
Revenue Next 2Y15.48%
Revenue Next 3Y18.86%
Revenue Next 5Y18.33%
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for SGFY. In the last year negative earnings were reported.
SGFY is valuated quite expensively with a Price/Forward Earnings ratio of 94.60.
The rest of the industry has a similar Price/Forward Earnings ratio as SGFY.
Compared to an average S&P500 Price/Forward Earnings ratio of 20.44, SGFY is valued quite expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 94.6 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of SGFY is on the same level as its industry peers.
The rest of the industry has a similar Price/Free Cash Flow ratio as SGFY.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 1516.44 | ||
| EV/EBITDA | 32.74 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
SGFY's earnings are expected to grow with 93.52% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y93.52%
EPS Next 3YN/A
5. Dividend
5.1 Amount
SGFY has a Yearly Dividend Yield of 1.26%.
SGFY's Dividend Yield is rather good when compared to the industry average which is at 2.54. SGFY pays more dividend than 85.84% of the companies in the same industry.
With a Dividend Yield of 1.26, SGFY pays less dividend than the S&P500 average, which is at 2.42.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.26% |
5.2 History
SGFY is new to the dividend game and has less than 3 years of track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DPN/A
EPS Next 2Y93.52%
EPS Next 3YN/A
30.49
+0.02 (+0.07%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners4.46%
Ins Owner Change0%
Market Cap5.46B
Analysts70
Price Target30.01 (-1.57%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.26% |
Yearly Dividend0.3
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-788.65%
Min EPS beat(2)-1114.2%
Max EPS beat(2)-463.11%
EPS beat(4)1
Avg EPS beat(4)-261.16%
Min EPS beat(4)-1114.2%
Max EPS beat(4)761.79%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-26.89%
Min Revenue beat(2)-42.43%
Max Revenue beat(2)-11.35%
Revenue beat(4)0
Avg Revenue beat(4)-14.07%
Min Revenue beat(4)-42.43%
Max Revenue beat(4)-0.2%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-51.79%
EPS NY rev (1m)0%
EPS NY rev (3m)-45.52%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.81%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.51%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 94.6 | ||
| P/S | 6.78 | ||
| P/FCF | 1516.44 | ||
| P/OCF | 171.13 | ||
| P/B | 8.7 | ||
| P/tB | N/A | ||
| EV/EBITDA | 32.74 |
EPS(TTM)-0.32
EYN/A
EPS(NY)0.32
Fwd EY1.06%
FCF(TTM)0.02
FCFY0.07%
OCF(TTM)0.18
OCFY0.58%
SpS4.5
BVpS3.5
TBVpS-0.9
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | N/A | ||
| ROE | N/A | ||
| ROCE | N/A | ||
| ROIC | 6.14% | ||
| ROICexc | 9.77% | ||
| ROICexgc | N/A | ||
| OM | 13.53% | ||
| PM (TTM) | N/A | ||
| GM | 45.33% | ||
| FCFM | N/A |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)5.48%
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y104.84%
ROICexc growth 5YN/A
OM growth 3Y50.3%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.69%
GM growth 5YN/A
F-Score3
Asset Turnover0.46
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.53 | ||
| Debt/FCF | 93.5 | ||
| Debt/EBITDA | 2.07 | ||
| Cap/Depr | 52.6% | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.62 | ||
| Quick Ratio | 1.62 | ||
| Altman-Z | 3.36 |
F-Score3
WACC9.37%
ROIC/WACC0.66
Cap/Depr(3y)53.08%
Cap/Depr(5y)45.67%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-390.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-253.85%
EPS Next Y200.72%
EPS Next 2Y93.52%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)23.33%
Revenue growth 3Y17.09%
Revenue growth 5YN/A
Sales Q2Q%232.24%
Revenue Next Year13.26%
Revenue Next 2Y15.48%
Revenue Next 3Y18.86%
Revenue Next 5Y18.33%
EBIT growth 1Y26.74%
EBIT growth 3Y75.98%
EBIT growth 5YN/A
EBIT Next Year153.12%
EBIT Next 3Y41%
EBIT Next 5Y25.5%
FCF growth 1Y-96.67%
FCF growth 3Y-39.43%
FCF growth 5YN/A
OCF growth 1Y-75.44%
OCF growth 3Y-8.54%
OCF growth 5YN/A